Skip to content
healthcare.dev

Fludeoxyglucose F18

NDC 60215-411, Fludeoxyglucose F18, injection, from The University of Texas MD Anderson Cancer Center.

Product NDC
60215-411
Status
Listed
Labeler
The University of Texas MD Anderson Cancer Center
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203246
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60215-411 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FLUDEOXYGLUCOSE F-18300 mCi/mL

Pharmacologic classes

Radioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]

Package NDCNDC-11Package
60215-411-306021504113027 mL in 1 VIAL, GLASS (60215-411-30)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/43954e40-bb95-4275-92ab-96211b7de907

Use it

Look up 60215-411 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60215-411 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60215-411. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.